EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SLC12A5 promotes hepatocellular carcinoma growth and ferroptosis resistance by inducing ER stress and cystine transport changes

Qing Tong iD, Wei Qin, Zheng-Hao Li, Chun Liu, Zi-Cheng Wang, Yuan Chu, Xun-Di Xu

Cancer Medicine · 2023-04 · 12 (7) · 8526-8541

DOI: 10.1002/cam4.5605 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 16.01.2023. Verfasst von Qing Tong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Provincial Key Laboratory of Hepatobiliary Disease Research & Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, The Second …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Ferroptosis, Symporters. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Program of Hunan Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatocellular carcinoma (HCC) has a poor prognosis and new effective treatments are needed. SLC12A5 plays important roles in multiple complex pathological states and is overexpressed in a variety of malignancies. However, the effects of SLC12A5 in HCC have not been determined.

Methods

SLC12A5 expression was assessed by immunostaining and western blotting. A cell viability assay was used to detect cell proliferation. Flow cytometry was used to evaluate the intracellular calcium concentration and cell cycle. Ferroptosis was detected by transmission electron microscopy, lipid peroxidation, and glutathione assays. Subcutaneous tumor formation experiments were used to validate the tumorigenic effect of SLC12A5 in vivo. RNA‐seq was used to evaluate the molecular mechanisms underlying the effects of SLC12A5. The therapeutic efficacy of targeting SLC12A5 was assessed in a patient‐derived xenograft (PDX) model.

Results

High SLC12A5 expression was strongly associated with a poor clinical prognosis and promoted HCC growth. Mechanistically, SLC12A5 promoted ER stress to enhance calcium release and upregulated PNCK expression levels. Concomitantly, PNCK was significantly activated by calcium ions released from the ER. PNCK activated and induced the phosphorylation of PI3K/AKT/mTOR pathway components. Furthermore, SLC12A5 inhibited ferroptosis in HCC by upregulating the expression of xCT, a cystine transporter.

Conclusion

High SLC12A5 levels were correlated with a poor prognosis, promoted tumorigenesis, and inhibited ferroptosis in HCC. These findings suggested that SLC12A5 is a therapeutic target and provide insight into the link between ER stress and ferroptosis in HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsFerroptosisSymportersHumansCystinePhosphatidylinositol 3-KinasesCalciumSignal TransductionCell Line, TumorK Cl- Cotransporters

Stichwörter der Autor:innen

SLC12A5cystine transportendoplasmic reticulum stressferroptosishepatocellular carcinoma

Substanzen

CystinePhosphatidylinositol 3-KinasesCalciumSymportersSLC12A5 protein, humanK Cl- Cotransporters

Autor:innen und Institutionen

  • Hunan Provincial Key Laboratory of Hepatobiliary Disease Research & Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Department of Hepato-Biliary-Pancreatic Surgery, The 3rd Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital), Urumqi, China.
  • Department of General Surgery, The South China Hospital of Shenzhen University, Shenzhen, China.

ORCID-Profile: Qing Tong

Förderung

  • Key Research and Development Program of Hunan Province of China

Zitieren

APA

Tong, Q., Qin, W., Li, Z. H., Liu, C., Wang, Z. C., Chu, Y., & Xu, X. D. (2023). SLC12A5 promotes hepatocellular carcinoma growth and ferroptosis resistance by inducing ER stress and cystine transport changes. Cancer Medicine, 12(7), 8526-8541. https://doi.org/10.1002/cam4.5605

Vancouver

Tong Q, Qin W, Li ZH, Liu C, Wang ZC, Chu Y, et al. SLC12A5 promotes hepatocellular carcinoma growth and ferroptosis resistance by inducing ER stress and cystine transport changes. Cancer Medicine. 2023;12(7):8526-8541. doi:10.1002/cam4.5605

BibTeX
@article{Tong2023,
  author = {Tong, Qing and Qin, Wei and Li, Zheng-Hao and Liu, Chun and Wang, Zi-Cheng and Chu, Yuan and Xu, Xun-Di},
  title = {SLC12A5 promotes hepatocellular carcinoma growth and ferroptosis resistance by inducing ER stress and cystine transport changes},
  journal = {Cancer Medicine},
  year = {2023},
  volume = {12},
  number = {7},
  pages = {8526--8541},
  doi = {10.1002/cam4.5605}
}
Kostenlos starten →